Patient-led education to improve diabetes management in a low-income setting: A randomized controlled trial in Aceh, Indonesia

The effect of peer education in addition to standard care on HbA1c and diabetes management compared to standard care in people with diabetes in Aceh, Indonesia.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN68253014

Enrollment

900

Registered

2019-02-28

Start date

2019-02-18

Completion date

Unknown

Last updated

2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes Nutritional, Metabolic, Endocrine

Interventions

Patients are recruited at their primary care health posts (Puskesmas). Randomization than takes place at the level of the Puskesmas, i.e. every participant from one Puskesmas is either in the treatmen

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes patients treated in Puskesmas in the intervention area for diabetes 2. Agreed to undergo the whole process of peer education 3. Agreed to carry out all biomarker measures included in the protocol 4. Aged 20-79 years

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes 2. Enrolled in other research program

Design outcomes

Primary

Measure	Time frame
Current primary outcome measure as of 29/12/2020: Glycated haemoglobin (HbA1c), measured using HbA1c measurement device with a drop of blood taken from the finger at baseline and after 20 months _____ Previous primary outcome measure: Glycated haemoglobin (HbA1c), measured using HbA1c measurement device with a drop of blood taken from the finger at baseline, after 9 and 18 months	—

Secondary

Measure	Time frame
Current secondary outcome measures as of 29/12/2020: 1. Total cholesterol, measured using point of care measurement device with drop of blood taken from finger at baseline and after 20 months 2. High-density lipoprotein, measured using point of care measurement device with drop of blood taken from finger at baseline and after 20 months 3. High-density lipoprotein, measured using point of care measurement device with drop of blood taken from finger at baseline and after 20 months 4. Triclycerides, measured using point of care measurement device with drop of blood taken from finger at baseline and after 20 months 5. Quality adjusted life years, measured using EQ-5D-3L at baseline and after 20 months 6. Physical Activity, measured via WHO Global Physical Activity Questionnaire at baseline and after 20 months _____ Previous secondary outcome measures: 1. Total cholesterol, measured using point of care measurement device with drop of blood taken from finger at baseline, after 9 and 18 months. 2. High-density lipoprotein, measured using point of care measurement device with drop of blood taken from finger at baseline, after 9 and 18 months. 3. High-density lipoprotein, measured using point of care measurement device with drop of blood taken from finger at baseline, after 9 and 18 months. 4. Triclycerides, measured using point of care measurement device with drop of blood taken from finger at baseline, after 9 and 18 months. 5. Quality adjusted life years, measured using EQ-5D-3L at baseline, after 9 and 18 months. 6. Physical Activity, measured via WHO Global Physical Activity Questionnaire at baseline, after 9 and 18 months.	—

Measure

Time frame

Current secondary outcome measures as of 29/12/2020: 1. Total cholesterol, measured using point of care measurement device with drop of blood taken from finger at baseline and after 20 months 2. High-density lipoprotein, measured using point of care measurement device with drop of blood taken from finger at baseline and after 20 months 3. High-density lipoprotein, measured using point of care measurement device with drop of blood taken from finger at baseline and after 20 months 4. Triclycerides, measured using point of care measurement device with drop of blood taken from finger at baseline and after 20 months 5. Quality adjusted life years, measured using EQ-5D-3L at baseline and after 20 months 6. Physical Activity, measured via WHO Global Physical Activity Questionnaire at baseline and after 20 months _____ Previous secondary outcome measures: 1. Total cholesterol, measured using point of care measurement device with drop of blood taken from finger at baseline, after 9 and 18 months. 2. High-density lipoprotein, measured using point of care measurement device with drop of blood taken from finger at baseline, after 9 and 18 months. 3. High-density lipoprotein, measured using point of care measurement device with drop of blood taken from finger at baseline, after 9 and 18 months. 4. Triclycerides, measured using point of care measurement device with drop of blood taken from finger at baseline, after 9 and 18 months. 5. Quality adjusted life years, measured using EQ-5D-3L at baseline, after 9 and 18 months. 6. Physical Activity, measured via WHO Global Physical Activity Questionnaire at baseline, after 9 and 18 months.

—

Countries

Indonesia

Contacts

Public ContactMarthoenis Marthoenis

marthoenis@unsyiah.ac.id+62 651 8053041

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 2, 2026